Adlyxin FDA Approved Drugs
0.15mg/3ml (0.05mg/ml) (subcutaneous solution)
0.3mg/3ml (0.1mg/ml) (subcutaneous solution)
Sanofi-aventis UsJul 27, 2016
- Combination treatment with a glitazone for improvement of glycemic control in type 2 diabetes mellitus patients.
- Improvement in glycemic control in type 2 diabetes mellitus patients by use of a pen injector.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.